Contents
Contents
A $1.75 million surgeon settlement was one of several civil resolutions in the SpineFrontier kickback case over alleged payments for implant use. The government alleged that SpineFrontier routed payments through a supposedly independent consulting business and set consulting hours by the number and type of surgeries. For someone inside device sales, finance or a surgical practice, the document could be the spreadsheet connecting those hours to implant revenue.
SpineFrontier manufactured and sold spinal implants, including cages, screws, plates and rods. Former employees brought two False Claims Act whistleblower cases, and the Department of Justice joined them in March 2020. The whistleblowers included a former sales manager, a former sales representative and a former employee of a KICVentures subsidiary.
The government’s complaint alleged that, from October 2013 through December 2018, SpineFrontier paid over $8 million through the consulting intermediary to approximately 35 surgeons. It alleged that those surgeons generated more than $100 million in revenue for the company. The money allegedly paid to surgeons bought access to a much larger stream of implant sales.
The payment chain depended on the surgeon’s influence over what the hospital purchased. The government’s civil complaint described spinal implants as physician preference items: the hospital bought them, but the operating surgeon generally selected them.
That split is central to the device business. A manufacturer can reach the institutional buyer by winning the surgeon’s preference. SpineFrontier sold to hospitals directly and through distributors, and the complaint alleged that it concentrated its sales efforts on persuading surgeons to use its products over competitors’ devices.
Payment for the implant also sat inside a larger transaction. The complaint explained that Medicare’s inpatient payment to the hospital included the cost of the device. The surgeon received a separate payment for professional services. A manufacturer could therefore earn revenue from the implant while the hospital and surgeon submitted the healthcare claims.
The later criminal indictment described another practical connection: implants often sat in trays or kits on consignment at the hospital. When a surgeon used an implant, the hospital paid the manufacturer and ordered a replacement for the tray. Product use could trigger both the sale and the replenishment record.
The civil complaint alleged that payments influenced the surgeon’s device choice, the chosen device generated a sale, and the resulting procedures generated false claims to federal health programs. The taxpayer’s bill arrived at the end of a purchasing decision the government said had been bought.
The government alleged that Impartial Medical Expert, marketed as Impartial Medical Experts and commonly called IME, gave the payments an appearance of independence. Its only client was SpineFrontier.
The complaint traced ownership back to the same business. It alleged that KICVentures and KIC Management Group owned and operated the manufacturer and the intermediary, and that SpineFrontier’s founder and chief executive controlled both. It identified IME’s sole employee as its business administrator, who was also the chief executive’s wife, and described the chief financial officer’s role in deciding what surgeons would be paid.
According to the complaint, SpineFrontier had previously contracted directly with surgeon consultants. The prospect of greater scrutiny under Open Payments helped drive the move to IME. The company presented that move to surgeons as outsourcing to a separate business, while the government alleged that it was a way to conceal the payment relationship.
The complaint’s account of the marketing was explicit:
To give IME a veneer of legitimacy, the Defendants falsely marketed IME as a separate referral company through which physicians could perform consulting and expert witness services, ostensibly for a variety of clients. In reality, [the founder] controlled both IME and SpineFrontier. After SpineFrontier began using IME as a vehicle to process purported consulting payments, IME served only one client—SpineFrontier.
Government allegation, United States ex rel. Birchall, Jr., Miller, and Bennett v. SpineFrontier, Inc., et al., complaint, paragraph 5
The complaint alleged that IME had a post office box instead of an office and retained a 5% administrative fee despite incurring virtually no administrative costs. In that account, SpineFrontier employees handled its work, and funds moved among companies under the same ownership.
That matters to someone who processes payments. The name on a consulting agreement can suggest an outside business, while the approvals, staffing and source of the money show who actually runs it.
The alleged formula commonly allowed one consulting hour for a cervical case and two for a lumbar case. The government’s announcement described payments generally set at $500 for a cervical procedure and $1,000 for a lumbar procedure, dependent on use of SpineFrontier devices.
The written agreement excluded surgical time spent using or implanting spinal products. The complaint alleged that the instructions surgeons received did the opposite: they could bill for time in surgery using the company’s devices.
The complaint alleged that the monthly review followed sales. Employees recorded each surgeon’s cases, sales and submitted consulting hours in a spreadsheet titled “Total Number of Surgeon Cases & Sales.” According to that account, the chief financial officer applied the procedure formula to approve hours and sometimes delegated the review to a junior financial analyst, whose instruction was to compare submitted hours with cases and sales.
The complaint alleged that the review also changed the time records. The complaint quoted an email from the chief executive:
The surgeons made a great point that we should manually reconcile their final payments with their IME numbers. So if they bill 14 hours and we pay for 10 hours we should change their online numbers to the 10 hours and not leave a discrepancy.
Chief executive’s email quoted in United States ex rel. Birchall, Jr., Miller, and Bennett v. SpineFrontier, Inc., et al., complaint, paragraph 96
The alleged instruction was to make the recorded hours match the payment. Someone reviewing the final time entry alone would miss the decision that produced it.
Product value mattered too. The complaint alleged that the chief financial officer told a surgeon he would be a more valuable consultant if he used more expensive implants, including InSpan. Other surgeons allegedly heard that more device use would support more consulting fees. In that account, the route to more approved consulting time ran through the operating room.
The government alleged that surgeons received payments even when they submitted no written product feedback. Where feedback did appear, it could be little more than a month name, a case count or a promise to keep evaluating products.
The complaint also described a failure to pass substantive feedback to the engineers who could use it. One sales representative complained to a mechanical engineer that nobody was paying attention to a surgeon’s comments. The company allegedly did not check with engineers or sales representatives to establish how much time a surgeon had actually spent discussing a device.
The complaint alleged that there was no cap on repeated evaluations of the same product. It said the company promoted that feature to recruit surgeons, paid for repeated evaluations of familiar devices such as pedicle screws, and largely ignored duplicative feedback.
For an engineer, that is a different view of the program from the one finance sees. Finance may see approved hours and a payment. Engineering may see no request, no discussion and no feedback reaching the people responsible for product changes. The case connects those views.
Five surgeons agreed to separate civil settlements in March 2020 over alleged sham consulting payments. The individual settlements ranged from $105,149 to $486,985, as the Justice Department later recorded in its account of the individual resolutions.
The government’s complaint described their admissions. They reported consulting hours substantially beyond the time they actually worked, received payment for hours they did not work, and followed instructions to bill by surgical case. They also admitted that the company did not ask for more consulting work or express dissatisfaction when their product evaluations contained little or no useful content.
Those admissions expose what the payment approval measured. A manufacturer paying for product development would have a reason to ask where the development work went. Here, the surgeons admitted that even empty evaluations did not produce a demand for more work.
A separate orthopedic surgeon’s April 24, 2020 settlement contained a direct admission: he estimated his consulting hours from the number of times he used SpineFrontier products in a month. He did not track actual consulting time and admitted that he could not document the hours submitted for payment.
He also sought and received consulting payments for time spent performing surgery, while Medicare and other federal health care programs were already paying him for those procedures. The manufacturer paid for time inside the operation, and the federal programs paid him to perform it.
The benefits extended to the surgical staff. The surgeon admitted accepting free meals for himself and his staff on almost every day he operated with a SpineFrontier product. The company spent thousands of dollars on those meals. The operating schedule connected both the purported consulting fees and the food to use of the manufacturer’s implants.
The 2021 indictment charged SpineFrontier and its executives with a kickback arrangement built around surgeon use of its devices. It alleged that the company selected consultants for their ability and willingness to use its products, paid for reported work that had not been performed, and created contracts and records to make the program appear legitimate.
The chief executive pleaded guilty in May 2025 to making false statements to the Centers for Medicare & Medicaid Services. The Justice Department’s account of his criminal case described a payment of $4,750 that he directed employees to report as consulting, knowing the surgeon had done no actual consulting work for it.
Open Payments makes manufacturer payments to physicians publicly accessible. Here, the reported category itself concealed the problem: a reader could see a consulting payment, while the chief executive knew there was no consulting behind it.
The civil agreement carried separate payments of $40,000 from the chief executive and $855,000 from his wholly owned company, KICVentures.
The chief financial officer pleaded guilty in May 2026 to conspiracy to violate the Anti-Kickback Statute. In its account of that criminal case, the Justice Department described his direction of more than $540,000 in bribes through sham consulting fees for work surgeons did not perform.
The contracts presented the payments as hourly consulting fees. The criminal account described payments for using SpineFrontier devices in procedures funded by Medicare, Medicaid and the Veterans Health Administration, with surgeons frequently doing only a small fraction of the reported work.
He also agreed to a fixed civil settlement payment totaling more than $150,000, with possible additional payments depending on his annual income. The government’s complaint described his role in approving reported hours according to device use.
Another surgeon pleaded guilty in August 2020 to a kickback conspiracy and obstruction, as the Justice Department’s later plea announcement recounts. The criminal charges against him alleged that the company tracked surgeon sales and used that information to decide consulting payments, regardless of the work performed.
The charges also alleged that, after a subpoena, the surgeon created documents purporting to show consulting work and produced those false documents to the government. It adds a concrete question to the consulting story: when did the claimed work acquire its paperwork?
A medical device distributor pleaded guilty to a kickback conspiracy and witness tampering in the related criminal prosecution. The criminal charges described his commissions on the products the surgeon implanted and alleged that he advised the surgeon to tell the government falsely that the consulting had been legitimate.
The distributor had a financial stake in the same device choices that generated the surgeon’s consulting payments. His role connects the manufacturer and the implanting surgeon through the sales channel, another place where someone inside the business could know how product use and compensation fit together.
In SpineFrontier, the government’s complaint connected what the manufacturer paid, what the surgeon did and what the hospital or physician billed. It described payment approvals, case-and-sales spreadsheets, submitted hours, product feedback and procedure claims.
An agreement that excluded surgical time sat beside alleged instructions to bill by surgical case. A program presented as product development sat beside allegations that engineers never received the feedback. Open Payments carried a consulting label for work the chief executive knew had not occurred.
The economic relationship can extend beyond a check. The 2020 Journal of Forensic and Investigative Accounting analysis, A Forensic Accountant’s Guide to the Most Potent Federal Laws Used Against Healthcare Fraud, describes kickbacks through direct, indirect and noncash compensation. In this case, that broader view connects the intermediary’s payments with the surgeon’s recurring staff meals.
The same focus on sales appeared in Life Spine’s civil settlement. Life Spine admitted that management reports compared surgeon payments with product use. One report calculated return on investment from surgeon-associated sales and consulting or royalty payments. When use fell, sales managers contacted surgeons or distributors to encourage more use.
SpineFrontier’s alleged case-based hours and Life Spine’s admitted return-on-investment report expose the same commercial question: what did the company expect its payments to buy? Someone who knows how those reports were used may understand the arrangement better than someone looking only at the signed contract. Our whistleblower experts can work with you to turn that knowledge into a case.
Yes. Former employees brought the SpineFrontier qui tam cases against the manufacturer, and the government joined them with allegations that its payments caused false claims for procedures. Sales and company insiders supplied the starting point for a case that followed the money through surgeons to federal health programs.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
If you saw consulting payments rise with implant sales, or approved hours for work that never reached the product team, talk with our whistleblower experts about what happened inside the business. We build your strongest device kickback case with you, match it with medical device kickback whistleblower lawyers, and stay beside you through the pursuit of a recovery.